Cancer nanomedicines were initially envisioned as magic bullets, travelling through the
circulation to target tumours while sparing healthy tissues the toxicity of classic …

Breast cancer is the most malignant tumor in women, and there is no absolute cure for it.
Although treatment modalities including surgery, chemotherapy, and radiotherapy are …

Abstract CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-
associated protein 9) is a potent technology for gene-editing. Owing to its high specificity …

Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Although several artificial nanotherapeutics have been approved for practical treatment of
metastatic breast cancer, their inefficient therapeutic outcomes, serious adverse effects, and …

Antibody‐based cancer therapy, one of the most significant therapeutic strategies, has
achieved considerable success and progress over the past decades. Nevertheless …

Minimizing drug leakage in systemic circulation, synchronizing the in vivo fate of multiple
drugs, and precisely controlling tumor locoregional drug release, remain challenging for …

In recent years, with the development of nanomaterials, the research of drug delivery
systems has become a new field of cancer therapy. Compared with conventional antitumor …

The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

Recently, 2D transition metal carbide, nitride, and carbonitrides (MXenes) materials stand
out in the field of tumor therapy, particularly in the construction of functional platforms for …